CLEMSON, South Carolina — Research conducted at Clemson University's Atomic and Medical Physics lab has led to the creation of a promising
medical technology company whose mission is to drastically improve radiosurgery outcomes and costs.
Other Institutions also belong to the Campus: the University of Milan; Cogentech, an IFOM - IEO consortium committed to developing leading genomic
technologies (nanotechnologies, proteomics, bioinformatics, disease models), the European School of Molecular Medicine (SEMM), that organizes training in emerging sectors of Biomedicine, offering the first European PhDs in Molecular Medicine,
Medical Nanotechnologies, Foundations of the Life Sciences and their Ethical Consequences; Genextra, a biotech
company whose mission is to develop new therapies against cancer and aging - related disease; Biopolo, a not for profit
company involved in the technological transfer of basic research to the productive system.